Literature DB >> 12064685

Prevalence of Campylobacter concisus in diarrhoea of immunocompromised patients.

Rune Aabenhus1, Henrik Permin, Stephen L W On, Leif P Andersen.   

Abstract

The importance of Campylobacter species other than C. jejuni/coli in diarrhoeal disease is largely unknown. We wished to determine the prevalence and clinical presentation of C. concisus infection in patients with enteric disease in a tertiary hospital. Stool specimens were routinely tested for the presence of Campylobacter species, by use of the filter isolation method. The medical records of the C. concisus-positive patients were reviewed. Of 224 Campylobacter isolates obtained, 110 were identified as C. concisus. Concomitant infection occurred in only 27% of cases. By means of protein profiling we assigned C. concisus into 2 groups. The predominant C. concisus group 2 was the only strain to infect immunocompetent patients and children: 71% of the infected patients were immunocompromised, the majority being adults (84%). C. concisus may be a frequent cause of diarrhoea in immunocompromised patients. Two groups of C. concisus were found and these groups possibly vary in their pathogenic potential.

Entities:  

Mesh:

Year:  2002        PMID: 12064685     DOI: 10.1080/00365540110080566

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  18 in total

1.  Delineation of Campylobacter concisus genomospecies by amplified fragment length polymorphism analysis and correlation of results with clinical data.

Authors:  Rune Aabenhus; Stephen L W On; Berit L Siemer; Henrik Permin; Leif P Andersen
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 2.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

3.  Campylobacter concisus pseudo-outbreak caused by improved culture conditions.

Authors:  Carlo Casanova; Alexander Schweiger; Niklaus von Steiger; Sara Droz; Jonas Marschall
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

4.  Diarrheal Mechanisms and the Role of Intestinal Barrier Dysfunction in Campylobacter Infections.

Authors:  Fábia Daniela Lobo de Sá; Jörg-Dieter Schulzke; Roland Bücker
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

5.  Evaluation of culture methods and a DNA probe-based PCR assay for detection of Campylobacter species in clinical specimens of feces.

Authors:  Majella Maher; Cathriona Finnegan; Evelyn Collins; Brid Ward; Cyril Carroll; Martin Cormican
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  First attempt to produce experimental Campylobacter concisus infection in mice.

Authors:  Rune Aabenhus; Unne Stenram; Leif Percival Andersen; Henrik Permin; Asa Ljungh
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

7.  Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota.

Authors:  Erik C von Rosenvinge; Yang Song; James R White; Cynthia Maddox; Thomas Blanchard; W Florian Fricke
Journal:  ISME J       Date:  2013-03-07       Impact factor: 10.302

8.  Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine.

Authors:  Vikneswari Mahendran; Stephen M Riordan; Michael C Grimm; Thi Anh Tuyet Tran; Joelene Major; Nadeem O Kaakoush; Hazel Mitchell; Li Zhang
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

9.  Sequencing and validation of the genome of a Campylobacter concisus reveals intra-species diversity.

Authors:  Nandan P Deshpande; Nadeem O Kaakoush; Hazel Mitchell; Karolina Janitz; Mark J Raftery; Simone S Li; Marc R Wilkins
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

Review 10.  Campylobacter concisus - A new player in intestinal disease.

Authors:  Nadeem Omar Kaakoush; Hazel Marjory Mitchell
Journal:  Front Cell Infect Microbiol       Date:  2012-02-03       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.